Drug recall · November 27, 2013
Spironolactone tablets recall
Why: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1
- Lots / codes
Lot #: V121211, Exp 03/31/2017
- Quantity
- 4848 bottles
- Company
- Greenstone Llc, Peapack, NJ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- September 4, 2013 · Voluntary: Firm initiated
- Classified
- November 20, 2013
- Reported
- November 27, 2013
- Ended
- April 13, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Spironolactone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.